Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
NEW YORK, May 25, 2015 /PRNewswire/ -- This BCC Research study provides an in-depth analysis and forecast of selected areas of the global healthcare acquired infections (HAI) market. The report offers forecasts by treatment segment and type of treatment from 2015 through 2020.
Use this report to:
- Receive analysis of the global healthcare-acquired infection (HAI) market by treatment area and by type of treatment.
- Learn about the most common HAI diseases encountered by clinicians and other personnel.
- Identify the structure of the HAI market and the chief challenges and opportunities it faces.
- Learn about the key players in the HAI industry.
Highlights
- The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.
- America currently holds 42% of the global market for HAI products, but that leadership position is expected to shrink to 40% by 2020.
- The asian market is expected to hold 25% of the global market for HAI products in 2015 and is expected to increase to 33% by 2020.
Introduction & Scope
INTRODUCTION
REASONS FOR DOING THE STUDY
The objective of this study is to provide an in-depth analysis and forecast of selected areas of the global healthcare-acquired infections (HAI) market. For purposes of this
report, HAI includes hospitals, nursing homes, outpatient surgery centers and dialysis centers. The focus of this report is on selected devices, pharmaceuticals and
environmental products currently used or under development for treatment of viral, bacterial and fungal infections. The global market for HAI products is estimated at between $17 billion and $22 billion in 2015 (depending on the products included in the study) with mid single-digit growth through 2020. The North American market and in particular the U.S. holds the largest market share of any region at 42% to 50% and the fastest growing regions for HAI treatments are Brazil and the Asian region, particularly China and India.
STUDY GOALS AND OBJECTIVES
Healthcare-acquired infections are viral, bacterial or fungal infections that patients acquire after they are admitted to a healthcare facility. Patients can acquire these
infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters and intravenous lines. This report is designed to investigate the global HAI market by treatment area and by type of treatment, with supporting tables and figures to illustrate projected growth.
Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, U.S., Mexico, Central America and South America); EMRA (i.e., Europe, the
Middle East, Russia and Africa); and Asia (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries).
SCOPE AND FORMAT
This report offers forecasts by treatment segment and type of treatment, from 2015 through 2020, including supporting analyses for projections. The main market segments are analyzed by pharmaceutical treatments, environmental treatments and infection control devices/products. This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market. This report provides background on the structure of the HAI market and the chief challenges and opportunities it faces. It offers the information needed to understand the current market and to address the emerging one. The report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investing consultants and
others interested in the HAI market, its products, its participants and its future.
METHODOLOGIES AND INFORMATION SOURCES
Information for this report was obtained from a variety of primary and secondary research sources, including industry analysts, annual reports and agencies and
organizations such as the U.S. Securities and Exchange Commission (SEC), the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the
U.S. National Institutes of Health (NIH), American Hospital Association (AHA), Infectious Disease Society of America (IDSA), American Society of Heating, Refrigerating and Air
Conditioning Engineers (ASHRAE), National Institute of Allergy and Infectious Diseases (NIAID), the National Hospital Discharge Survey (NHDS) and government agencies
outside the U.S. Secondary sources include literature searches, journal articles, product literature and press releases.
When precise information was not available, a consensus has been made using reasonable assumptions and estimates based on historical data.
Read the full report: http://www.reportlinker.com/p0619272-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article